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Background: Endoplasmic reticulum (ER) stress-induced apoptosis plays a major role in various diseases, including
spinal cord injury (SCI). Nerve growth factor (NGF) show neuroprotective effect and improve the recovery of SCI,
but the relations of ER stress-induced apoptosis and the NGF therapeutic effect in SCI still unclear.
Methods: Young adult female Sprague-Dawley rats’s vertebral column was exposed and a laminectomy was done
at T9 vertebrae and moderate contusion injuries were performed using a vascular clip. NGF stock solution was
diluted with 0.9% NaCl and administered intravenously at a dose of 20 μg/kg/day after SCI and then once per day
until they were executed. Subsequently, the rats were executed at 1d, 3 d, 7d and 14d. The locomotor activities of
SCI model rats were tested by the 21-point Basso-Beattie-Bresnahan (BBB) locomotion scale, inclined plane test and
footprint analysis. In addition, Western blot analysis was performed to identify the expression of ER-stress related
proteins including CHOP, GRP78 and caspase-12 both in vivo and in vitro. The level of cell apoptosis was determined
by TUNEL in vivo and Flow cytometry in vitro. Relative downstream signals Akt/GSK-3β and ERK1/2were also
analyzed with or without inhibitors in vitro.
Results: Our results demonstrated that ER stress-induced apoptosis was involved in the injury of SCI model rats.
NGF administration improved the motor function recovery and increased the neurons survival in the spinal cord
lesions of the model rats. NGF decreases neuron apoptosis which measured by TUNEL and inhibits the activation
of caspase-3 cascade. The ER stress-induced apoptosis response proteins CHOP, GRP78 and caspase-12 are inhibited
by NGF treatment. Meanwhile, NGF administration also increased expression of growth-associated protein 43
(GAP43). The administration of NGF activated downstream signals Akt/GSK-3β and ERK1/2 in ER stress cell model
in vitro.
Conclusion: The neuroprotective role of NGF in the recovery of SCI is related to the inhibition of ER
stress-induced cell death via the activation of downstream signals, also suggested a new trend of NGF translational
drug development in the central neural system injuries which involved in the regulation of chronic ER stress.
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Spinal cord injury (SCI) represents a severe health prob-
lem worldwide usually associated with life-long disabil-
ities. SCI often affects individuals in their productive age,
having an enormous social and economic impact. Trau-
matic SCI evolves through two phases: normally, the pri-
mary injury and the secondary injury which includes
disturbances in ionic homeostasis, local edema, ischemia,
focal hemorrhage, free radicals stress and inflammatory
response [1]. Substantial research efforts are being de-
voted to limit the evolution of secondary damage through
the development of neuroprotective measures [2]. Several
reports have suggested that apoptosis plays a pivotal role
in this secondary damage in animal models and in human
tissue by causing progressive degeneration of the spinal
cord [3]. However, the exact mechanism of cell death has
not been fully clarified.
Endoplasmic reticulum is the important intracellular or-
ganelle for the synthesis and folding of secreted and
membrane-bound proteins and the first site of the
secretory pathway [4]. Some of the events triggered by the
secondary injury, such as disturbance of calcium homeo-
stasis, accumulation of unfolded or misfolded proteins
and hypoglycemia, can trigger ER stress [5,6]. Conse-
quently, to restore the proper function of ER and trigger
the unfolded protein response (UPR), contribute to this
adverse situation [7]. During SCI, prolonged ER stress
without the cellular protective mechanisms by UPR even-
tually results in neural apoptosis [8,9]. Several apoptosis
mediators are implicated in ER stress-associated cell
death, such as glucose-regulated protein 78 (GRP78), the
transcription activation of the C/EBP homologous tran-
scription factor (CHOP) and the activation of ER-
associated caspase-12 [10]. Accumulation of unfolded pro-
teins in the ER lumen, inhibition of protein synthesis de-
pletion of Ca2+ from ER stores, activation of CHOP/
GADD153 expression and caspase-12, all these events
suggest the crucial role of ER in neuronal cell apoptosis
signaling after SCI [8,11]. Nevertheless, the latest study in-
dicated that the deletion of the pro-apoptotic CHOP did
not result in improvement of locomotor function after se-
vere contusive spinal cord injury [12]. Although ER stress
has been confirmed played important role in SCI, but the
relative mechanism still need to further investigation.
Nerve growth factor (NGF) is a member of the neuro-
trophin family and an important regulator of neural sur-
vival, development, function and plasticity. In addition,
NGF can also protect cells against oxidative stress or
toxin-induced apoptosis [13,14]. The activation of the
TrkA receptor and intracellular kinase pathways, includ-
ing the phosphatidylinositol-3 kinase (PI3K)/Akt and
mitogen-activated protein kinase (MAPK) pathways is in-
volved in the neurogenesis and protective effect of NGF
[15,16]. More recently, NGF has been demonstrated a roleof promoting cell survival by counteracting apoptosis
caused by ER stress [17,18]. It has been indicated that
nerve growth factor (NGF) show neuroprotective effect
and improve the recovery of SCI [19,20]. However, the
molecular mechanism of NGF treatment in the recovery
of SCI still undefined completely, especially the relations
of ER stress-induced apoptosis and the NGF therapeutic
effect in SCI has not been investigated clearly. The precise
molecular mechanisms by which ER stress leads to cell
survival/death remains enigmatic, with multiple potential
participants described above, but little clarity about which
specific death effectors dominate particularly in SCI, espe-
cially the mechanism and effective pathway in the treat-
ment with exogenous neurotrophic factors.
In this study, we investigated the effect of exogenous
NGF and the involvement of ER stress in a regional and
time-dependent manner following clip compression-
induce SCI. Our results indicated that the ER stress-
induced apoptosis with the activation of CHOP, GRP78
and caspase-12 was involved in the early stage of SCI.
NGF administration improved the locomotor function of
SCI model rats, increased the neurons survival. The pro-
tective effect of NGF is related to the inhibition of ER
stress-induced apoptosis, decreased the levels of CHOP,
GRP78 and caspase-12, which also increased the expres-
sion of growth-associated protein 43 (GAP43). These re-
sults may certainly help in understanding the basic
events involved in ER stress-mediated cell survival/death
signaling pathways and the molecular mechanism in the
recovery of SCI and other central nerve system diseases,
which also contributes to the translational research of
NGF in drug development.
Materials and methods
Cell culture and viability assay
PC12 cells were purchased from the Cell Storage Center
of Wuhan University (Wuhan, China). PC12 Cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM,
Invitrogen, Carlsbad, CA) supplemented with heat-
inactivated 10%fetal bovine serum (FBS, Invitrogen,
Carlsbad, CA), 5% horse serum, and antibiotics (100
units/ml penicillin, 100 μg/ml streptomycin), incubated
in a humidified atmosphere containing 5% CO2 at 37°C.
PC12 cells were seeded on 96-well plates (5 × 103 cells/
well) and treated with different concentrations of ER
stress activator, various doses of thapsigargin (TG, 0,
1μM, 2.5μM, 5μM, 10μM) for 24h. For determining the
effect of NGF, 100ng/ml NGF was added 2 h prior to the
addition of TG [21]. Cell viability was determined by
MTT assays. 20 μl MTT (3-(4,5-dimethylthiazol-2-yl)-2,
5-diphe-nyltetrazolium bromide (5 mg/ml in PBS) was
add to the cells for 4 h. Cells were washed with PBS (pH
7.4), and 150 μl DMSO was added to solubilize the for-
mazan crystals. Fluorescence intensity was measured at
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NGF were used for the subsequent experiments.
To further evaluate the effect of PI3K/Akt and ERK1/2
activation on oxidative injury, cells were pretreated with
specific inhibitors LY294002 (20 μM) and PD98059 (20
μM) 2 h before the addition of NGF as described previ-
ously [22]. Then analyze Cell signaling and cell survival.
Pretreatment compounds were not removed from the
media before successive treatment conditions. All exper-
iments were performed in triplicate.
Spinal cord injury and NGF administration
Young adult female Sprague-Dawley rats aged 8 weeks
(220-250g) were purchased from Animal Center of
Chinese Academy of Sciences, Shanghai, China. Animals
were maintained for at least 7 d before the experiment
in a temperature-regulated room (23°C-25°C) on a 12-h
light/dark cycle and free to water and food. The protocol
of the animal using and caring was conformed to Guide
for the Care and Use of Laboratory Animals from Na-
tional Institutes of Health and approved by the experi-
mental procedures were approved by the Animal Care
and Use Committee of Wenzhou Medical College. Ani-
mals were anaesthetized by an intraperitoneal injection
of 10% chloralic hydras (3.5 ml/kg). Then rats were posi-
tioned on a cork platform. The skin was incised along
the midline of back, and the vertebral column was ex-
posed and a laminectomy was done at T9 vertebrae and
moderate contusion injuries were performed using a vas-
cular clip ( 2 min, 30 g forces, Oscar, China). Control
group animals received the same surgical procedures,
but impaction was not applied to the spinal cord. Post-
operative care involved manual urinary bladder empty
twice daily until they return of bladder function and ad-
ministration of cefazolin sodium (50 mg/kg, i.p.).
NGF was purchased from Sigma (Sigma–Aldrich, St.
Louis, MO, USA). The stock solution was diluted with
0.9% NaCl and administered intravenously at a dose of
20 μg/kg/day after 30 min of SCI and then once per day
until they were executed. Control groups were received
equivolumetric administration of NaCl at the corre-
sponding times. Following treatment with either vehicle
or NGF, animals were treated uniformly until the final
analysis of the data. All experimental animals were re-
ceived daily rehabilitation procedures, including passive
mobilization of hind legs twice daily. Subsequently, the
rats were executed at 1, 3, 7 and 14 d.
Behavioral tests
In order to examine the locomotor function after injury,
behavioral analyses were performed by trained investiga-
tors who were blind to the experimental conditions.
Using the 21-point BBB locomotion scale, inclined plane
test and footprint as described elsewhere [23] to evaluateopen-field locomotion. BBB is a 22-point scale (scores 0-
21) that systematically and logically follows recovery of
hindlimb function from a score of 0, indicative of no ob-
served hindlimb movements, to a score of 21, representa-
tive of a normal ambulating rodent.
The inclined plane test was performed via a testing ap-
paratus [24]. The maximum angle at which a rat could re-
tain its position for 5 sec without falling was recorded for
each position, and averaged to obtain a single score for
each animal. Footprint analysis was performed through
dip the animal’s hindpaws with blue dye as described else-
where [25]. The animal was allowed to walk across a nar-
row box (1 m long and 7 cm wide). The footprints were
scanned, and digitized images were analyzed.
Immunohistochemistry and histology
Sham and SCI rats (n = 6) were deeply re-anesthetized
with 10% chloralic hydras (3.5 ml/kg, i.p.), and perfused
with 0.9% NaCl, followed by 4% paraformaldehyde in
0.01M phosphate buffered saline (PBS, PH = 7.4) at 1, 3,
7 and 14 d. A T7–T9 spinal cord segment around the
lesion epicenter was removed, post-fixed in cold 4%
paraformaldehyde overnight, and embedded in paraffin.
Transverse paraffin sections (5 μm thickness) were mounted
in Poly-L-Lysine-coated slides for histopathological examin-
ation. The lesion epicenter stained with hematoxylin
and eosin for HE staining. One stained with Cresyl Vio-
let for Nissl stain following the instruction. Consecutive
slides were immunostained. The slide were incubated in
3% H2O2 for 15 min and 80% carbinol for 30 min and
then in blocking solution for 1 h at room temperature.
Subsequently, the sections were incubated at 4°C over-
night with the following primary antibodies: CHOP
(1:150), GRP78 (1:200), and caspase-12 (1:2000, Santa
Cruz Biotech, CA, USA). After triple washing in PBS, the
sections were incubated with horseradish peroxidase-
conjugated secondary antibodies for 2 h at 37°C. The reac-
tion was stopped with 3, 3-diaminobenzidine (DAB). The
results were imaged at a magnification of 400 using a
Nikon ECLPSE 80i (Nikon, Japan). The optical densities
and positive neuron numbers of CHOP, GRP78 and
caspase-12 were counted at 5 randomly selected fields per
sample in spinal anterior horn and quantification by
Imagepro-Plus. Histology and immunohistochemistry for
each marker were performed simultaneously in all spinal
cord samples as well as negative controls without primary
antibodies.
Western blot analysis
For the in vivo protein analysis, a spinal cord segment
(0.5 cm length) at the contusion epicenter was dissected
at 1, 3, 7 and 14 d and soon stored at -80°C for western
blotting. For protein extraction, the tissue was homoge-
nized in modified RIPA buffer (50 mM Tris-HCl, 1%
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ing protease inhibitor cocktail (10 μl/ml, GE Healthcare
Biosciences, PA, USA). The complex was then centri-
fuged at 12,000 rpm and the supernatant obtained for
protein assay. For ER stress model In vitro, PC12 cells
were lysed in RIPA buffer (25 mM Tris-HCl, 150 mM
NaCl, 1% Nonidet P-40, 1% sodium deoxycholate, and
0.1% SDS) with protease and phosphatase inhibitors.
The extracts above were quantified with bicinchoninic
acid (BCA) reagents (Thermo, Rockford, IL, USA). We
separated proteins (50 μg) on a 11.5% gel and transferred
tem onto PVDF membrane (Bio-Rad, Hercules, CA,
USA). The membrane was blocked with 5 % milk (Bio-
Rad) in TBS with 0.05 % tween 20 for 1h and incubated
with the antibodies: CHOP (1:300, Santa Cruz Biotech-
nology, CA, USA), GRP78 (1:300, Santa Cruz Biotech-
nology), caspase-12 (1:1000, Santa Cruz Biotechnology),
caspase-3 (1:1000, Santa Cruz Biotechnology) in 5% milk
in TBS with 0.05% tween 20 overnight. The membranes
were washed with TBS for 3 times and treated with
horseradish peroxidase-conjugated secondary antibodies
for 1h at room temperature. Signals were visualized by
ChemiDicTM XRS + Imaging System (Bio-Rad), and
band uensities were quantified with Multi Gauge Software
of Science Lab 2006 (FUJIFILM Corporation, Tokyo,
Japan). We analyzed relative densities of the bands with
Quantity One (version 4.5.2; Bio-Rad). Quantities of band
densities were normalized using GAPDH.
Apoptosis assay
DNA fragmentation in vivo was detected by one step
TUNEL Apoptosis Asssy KIT (Roche, Mannheim, Germany).
Transverse paraffin sections (5 μm thickness) were
deparaffinized and rehydrated. Sections were treated
with 10 μg/mL proteinase K at 37°C for 30 min, then in-
cubated with 50 μL of TUNEL inspection fluid for 60
min before rinsed three times with PBS. Images were
taken at × 400, using 488 nm wavelengths light for exci-
tation and 530 nm for emission. Images were captured
with a Nikon ECLIPSE Ti microscope (Nikon, Japan).
The apoptotic rates of the PC-12 cells treated with TG
and NGF were measured using a PI/Annexin V-FITC kit
(Invitrogen, Carlsbad, CA, USA), then analyzed by FACS-
can flow cytometer (Becton Dickinson, Franklin Lakes,
NJ, USA) as the manual description.
Immunofluorescence staining
The sections were incubated with 10% normal donkey
serum for 1 h at room temperature in PBS containing
0.1% Triton X-100, followed by incubation with appro-
priate primary antibodies overnight at 4°C in the same
buffer. The nuclears were stained with Hoechst 33258
(0.25 μg/ml) dye. For neurons and GAP43 detection, the
following primary antibodies were used based on differenttargets: anti-NeuN (1:500, Millipore), anti-GAP43 (1:50,
Santa Cruz, Biotechnology, Santa Cruz, CA). After pri-
mary antibody incubation, sections were washed for 4 × 10
min at room temperature, followed by incubation with Alexa
Fluor594/647 donkey anti-mouse/rabbit, Alexa-Fluor488/
594 donkey anti-rabbit/mouse, or Alexa-Fluor488/594 don-
key anti-goat secondary antibody (1:500; Invitrogen Corpor-
ation, Carlsbad, CA, USA) for 1 h at room temperature.
Sections were then washed with PBS containing 0.1% Triton
X-100 for 4 × 10 min, followed by 3 × 5 min with PBS and
briefly with water. All images were captured on Nikon
ECLIPSE Ti microscope (Nikon, Tokyo, Japan).
Statistical analysis
Data were expressed as mean ± SEM. Statistical signifi-
cance was determined with Student’s t-test when there
were two experimental groups. For more than two groups,
statistical evaluation of the data was performed using
One-way Analysis-of-variance (ANOVA) test, followed by
Dunnett’s post hoc test with the values P < 0.05 considered
significant.
Results
ER stress-induced apoptosis is involved in the early stage
of SCI model in vivo
In order to evaluate the role of ER stress in SCI, we per-
formed the SCI models as described above [26]. After
SCI, animals showed dramatic and bilateral hind limb
paralysis with no movement at all or only slight move-
ments of a joint from the first hours post-injury when
observed during open-field walking. Then treated with
NGF at three dose (5, 10, 20 μg/kg) beginning 1 d after
injury and then once daily for 14 consecutive days.
Functional recovery was then evaluated for 2 weeks after
injury using the BBB rating scale [23], inclined plane test
[24], and footprint recordings [25]. We scored animal
locomotor activity according to the BBB scale 1d after
SCI, and the BBB scores showed that rats with SCI could
no longer move (score 0 to 1) while the sham-operated
rats walked normally (score 21). There were significant
differences between both groups (P < 0.0001; Figure 1B).
The locomotor function increased progressively during
the experimental period. At 3 d and 7 d after contusion,
the BBB scores were 3.67 ± 0.88 (P < 0.0001) and 8.00 ±
0.58 (P < 0.0001). Until 14 d after injury, the BBB scores
were achieve 12 ± 0.88, which corresponds to slight step
placement with weight support (Figure 1B).
The lesion center was characterized by the destruction
of gray and white matter. The neurons in the spinal cord
of the sham-operated group had normal morphology,
with a clear cytoplasm, and uniform and clear nuclei.
Compared with the sham operation group (1 d post-
trauma), the gray matter of the SCI group exhibited
large hemorrhages. The motor neurons in the anterior
Figure 1 Assessment of SCI model rats. A. HE staining results of SCI rat at 1, 3, 7 and 14 d after contusion. B. The BBB scores of SCI model rat
at 1, 3, 7 and 14 d after contusion. The score of the sham group was 21 points (meaning normal locomotion). ** P < 0.01 versus the sham group.
Data are the mean values ± SEM, n = 6. C. TUNEL apoptosis assay of model rat spinal cord lesion. Immunofluorescence results of the TUNEL assay.
Bright green dots were deemed positive apoptosis cell. Motor function was evaluated by Nissl staining. Big, blue dots were deemed as motor
neuron. Magnification was 20 ×. D. The analysis of apoptosis cell 1, 3, 7 and 14 d after spinal cord injury lesions. The percentage of apoptosis was
counted from 3 random 1 × 1 mm2 areas. ** P < 0.01 versus the sham group. Data are the mean values ± SEM, n = 6.
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compared with the sham group, consistent with ischemic
change. Progressive destruction of the dorsal white mat-
ter and central gray matter tissue was found 3 d post-injury. The lesion segments displayed hemorrhagic ne-
crosis, neuron loss, karyopyknosis, and infiltrated poly-
morphonuclear leukocytes and macrophages. In the
segments collected 7 d post-injury and 14 d post-injury,
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generation, but demyelination appeared as well as nu-
merous cavities (Figure 1A). The cell apoptosis in the
spinal lesions were detected by TUNEL staining and the
bright green dots were deemed as TUNEL-positive cells
in the lesions. Sham group showed no apoptosis positive
cells. The numbers of TUNEL-positive cells increased
significantly 1d after injury and were maximal at 3 d,
then decreasing gradually (Figure 1C, D). The effect of
SCI on the number of motor neurons in the spinal cord
was investigated by Nissl staining. As shown in Figure 1C,
SCI rat showed an extensive loss of large anterior horn
cells at 1d and 3 d. In contrast, motor neurons were in-
creased in the anterior horns at 7 d. At 14 d group com-
pared with sham group, motor neurons were remarkably
preserved in the anterior horns.
We next investigate the molecular mechanism of ER
stress-induced apoptosis in the SCI, immunohisochemis-
try staining was applied firstly. It was found that GRP78,
CHOP, caspase-12 positive cells were expressed in both
gray matter and white matter, and the staining was moreFigure 2 ER stress-induced apoptosis was involved in the early stage
sham, 1, 3, 7 and 14 d after spinal cord injury lesions groups. B. Analysis of
P < 0.05 versus the sham group, ** P < 0.01 versus the sham group, # P < 0.
versus the 7 d group. Data are the mean values ± SEM, n = 6.intense in the gray than white matter (Figure 2A). The
numbers of CHOP, GRP78, caspase-12 positive cells and
optical density increased significantly, and were all max-
imal at 3 d (Figure 2A, B). Thereafter, the number of
positive cells and optical density gradually reduced but
were still observed after 7d contusion (Figure 2A, B).
Until the 14d after injury, CHOP, GRP78, caspase-12
positive cells next to normal.
NGF increases the survival of neurons and improves the
recovery of SCI
To evaluate the therapeutic effect of NGF on SCI, model
rats were treated with NGF by tail intravenous injection.
To determine the dosage of NGF firstly, three dosage of
NGF (5, 10 and 20 μg/kg/d) was used for administration.
As show in BBB scores (Figure 3A) and the inclined
plane test (Figure 3B), the protective effect of NGF
reached a maximum at 20 μg/kg/d. The BBB locomotor
rating scores of SCI group were assessed at 1, 3, 7 and
14 d post-surgery. The hindlimbs were paralyzed imme-
diately after injury, and the rats recovered extensiveof SCI. A. Immunohistochemistry for GRP78, CHOP and caspase-12 in
the positive cells of the immunohistochemistry results. * represents
05 versus the 1d group, and $ P < 0.05 versus the 3 d group, & P < 0.05
Figure 3 BBB scores and inclined plane test of different concentration of NGF treated model rats. A. BBB scores and B. inclined plane test
after spinal cord injury. *P < 0.05 versus sham group, **P < 0.01 versus sham group.
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NGF treatment after injury significantly increased the
hindlimb locomotor function, as assessed by BBB scores
(Figure 4A). We previously discovered that nerve growth
factor (NGF) reduced the SCI. As shown in Figure 4,
NGF improve the BBB locomotor function compared to
the SCI group at 7 d (P = 0.0132), and the effects be-
come obviously at 14 d after contusion (P = 0.0011). At
14 d after injury, the 20 μg/ml NGF group reached at
11.67 ± 0.33, while the control group at 8.667 ± 0.33.
The angle of incline, determined 2 weeks after injury,
was also significantly higher in NGF treated rats com-
pared with the vehicle control group (P < 0.01, Figure 4B).
As shown in Figure 4C, footprint analyses for NGF treated
rats at 14 d after SCI disclosed fairly consistent hindlimb
coordination and very little toe dragging. These findings
were comparable to those in the sham control animals. ByFigure 4 NGF improves the locomotor activity of SCI rats. A. The BBB
with NGF group. * P < 0.05 versus the SCI group, and ** P < 0.01 versus the
group at 14 days after SCI show that NGF treated rats display fairly consiste
contrast, vehicle control rats show consistent dorsal stepping and extensivecontrast, the footprints obtained from vehicle-treated ani-
mals showed inconsistent coordination and extensive
drags as revealed by ink streaks extending from both hin-
dlimbs (Figure 4C).
HE staining results of the spinal cord samples from
different groups were shown in Figure 5A. Compared
with sham operation group, progressive destroy of the
dorsal white matter and central gray matter tissue were
found in the 7 d SCI group. Compared with the SCI
group, NGF treatment showed significant protective ef-
fect with less necrosis, karyopyknosis, infiltrated poly-
morphonuclear leukocytes and macrophages. The effect
of NGF on the number of motor neurons in the spinal
cord was also investigated. As shown in Figure 5B, the
vehicle control group showed an extensive loss of large
anterior horn cells. In contrast, motor neurons were re-
markably preserved in the anterior horns in rats treatedscores and B. incline plane test of sham, SCI group and SCI rat treated
SCI group, n = 6. C. Representative footprints obtained from each
nt weight-support plantar stepping and very little toe dragging. In
toe dragging.
Figure 5 Treatment with NGF improves the recovery of SCI and the survival of neurons. A. HE staining results of the sham, SCI group and
SCI rat treated with NGF group. B. NeuN staining and Nissl staining results of the sham, SCI group and SCI rat treated with NGF group. C. The
analysis of Nissl body after spinal cord injury lesions in different groups. ## represents P < 0.01 versus the sham group, ** P < 0.01 versus the SCI
group. n = 6. D. Analysis of the positive neurons of the NeuN staining results. ## represents P < 0.01 versus the sham group, ** P < 0.01 versus the
SCI group. n = 6.
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rats. No significant difference was observed in rats be-
tween sham group and NGF group.
To further confirm the protective effect of NGF, we in-
vestigated the survival of neurons directly by immuno-
fluorecence staining. As shown in Figure 5B, spinal cord
neurons in both of the white and gray matter tissue were
marked by neuronal marker NeuN. The positive staining
cells decreased significantly after SCI at 7 d, and increased
by NGF treatment (P < 0.0001). All of these data indicated
that NGF administration shown protective effect on neur-
onal cells and improved the recovery of SCI significantly.
NGF inhibits ER stress induced apoptosis and
up-regulates the neuroprotective factors
To illustrate whether the molecular mechanism of NGF
is related to the regulation of ER stress, the proteinexpression of ER stress-induced apoptosis were detected
by immunohistochemistry staining and Western blot. As
shown in Figure 6A and Figure 6B, ER stress-induced
apoptosis proteins (CHOP, GRP78 and caspase-12) posi-
tive cells and optical density gradually reduced by NGF
administration after 7d contusion. The protein expres-
sion was also detected by Western blot, it was found
that the levels of CHOP, GRP78 and caspase-12 protein
decreased by the treatment of NGF, compared with the
SCI group after 7 d contusion (Figure 6D, E). Until 14
days, the positive cells and protein expression all tend to
normal level.
The protein GAP43 is expressed in developing and re-
generating neurons which is often used to score the con-
dition of neural regeneration. The levels of GAP43 were
detected by immunofluorecence staining, it was found
that the positive red fluorescence signal in the cytoplasm
Figure 6 NGF administration inhibits the expressions of ER stress-induced apoptosis response proteins, GRP78, CHOP and caspase-12.
A. Immunohistochemistry for GRP78, CHOP and caspase-12 in the sham, 7d and 14d after spinal cord injury lesion and NGF treatment 7 d and
14d after injury groups. B. Analysis of the positive cells and C. optical density of the immunohistochemistry results. ** P < 0.01 versus the SCI (7d)
group, # represents P < 0.05 versus the SCI(14d) group, Data are the mean values ± SEM, n = 6. D. Protein expressions of GRP78, CHOP and
caspase-12 for the sham, SCI and NGF treatment groups. GAPDH was used as the loading control and for band density normalization. E. The
optical density analysis of GRP78, CHOP, and caspase-12 protein. ** P < 0.01 versus the sham group. Data are the mean values ± SEM, n = 6.
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compared with the SCI group at 7d contusion (Figure 7A).
As shown in Figure 7B and C, Western blot analysis of
GAP43 protein also demonstrated that the expression of
GAP43 increased in the NGF treatment group, compared
with SCI group after 7d contusion (P =0.0019), which was
consistent with the results of immunofluorecence staining
analysis.
To investigate the effect of NGF on cell death after
SCI, we performed TUNEL staining with sections ob-
tained at 7 d after injury, the TUNEL-positive cells were
obviously decreased in the NGF-treated rat compared
with the vehicle-treated rat (Figure 8A). When the
TUNEL-positive cells were counted, the number of
TUNEL-positive cells was significantly lower in the
NGF treated rats compared to the vehicle-treated rat
(P =0.0019) (Figure 8B). In the Western blot analysis,
the expression of Caspase3 protein was significantly in-
creased in the NGF-treated rat and the vehicle-treated
rat compared with in the sham controls (Figure 8C, D).In addition, the activated Caspase3 expression in the
NGF-treated rat was relatively lower than that in the
vehicle-treated rat.
The protective role of NGF is related to the activation of
downstream signal pathways PI3K/Akt/ GSK-3β and ERK1/2
It has been indicated that PI3K/Akt/GSK-3β and ERK1/2
pathways are the main downstream signals which acti-
vated by NGF, two pathways are related to the cell sur-
vival, differentiation and migration [27,28]. We next
detected whether the protective effect of NGF in the re-
covery of SCI also involved in the activation of these two
signal pathways. Western blot analysis demonstrated that
the expressions of the phosphoryations of Akt (p-Akt),
ERK1/2 (p-ERK1/2) and GSK-3β (p-GSK-3β, downstream
of Akt signal) decreased after SCI contusion. The de-
creases of phosphoryations were recovered by NGF treat-
ment at 7 d (Figure 9A, B). These data indicated that both
of the PI3K/Akt and ERK1/2 signals were involved in the
role of NGF in the recovery of SCI.
Figure 7 NGF treatment increases the level of GAP43 in spinal cord lesions. A. Immunofluorescence staining results of GAP43; the nuclear is
labeled by Hoechst (blue), the neurons with obvious GAP43 signals are labeled by bright right dots, magnification was 20 ×. B. The protein
expressions of GAP43 in sham, SCI rats and SCI rats treated with NGF groups. GAPDH was used as the loading control and for band density
normalization. C. The optical density analysis of GAP43 protein. ** P < 0.01 versus the SCI group, and ## represents P < 0.01 versus the sham
group. Data are the mean values ± SEM, n = 6.
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protective effect of NGF in the chronic ER stress model
in vitro
To further confirm the role of NGF in the ER stress-
induced apoptosis in vitro, we used ER stress activator TG
treated PC-12 cells to replicate the apoptosis model. As
shown in Figure 9C and D, cell viability decreased with the
increase of TG concentration (P = 0.0019), combinationFigure 8 NGF decreases the level of apoptosis in spinal cord lesions.
Immunofluorescence result of the TUNEL assay. Bright green dots were dee
apoptosis cell of the sham, SCI and NGF treatment groups. The percentage
expressions of caspase-3 for the sham, SCI and NGF treatment groups. D. T
SCI group, and # P < 0.05 versus the sham group. ** P < 0.01 versus the SCI
values ± SEM, n = 6.with NGF partially increased cell viability compared with
TG group (P = 0.0004). Cell apoptosis was analyzed by
FACScan with PI/Annexin V-FITC staining, it was found
that NGF inhibited the apoptosis induced by TG in PC-12
cells, compared with TG group (P = 0.0003, Figure 9E, F).
To investigate the molecular mechanism of NGF in
the ER stress-induced cell apoptosis model in vitro, two
signal inhibitors LY294002 for PI3K/Akt and PD98059A. TUNEL apoptosis assay of model rat spinal cord lesions.
med positive apoptosis cell, magnification was 20×. B. The analysis of
of apoptosis was counted from 3 random 1 × 1 mm2 areas. C. Protein
he optical density analysis of caspase-3 protein. * P < 0.05 versus the
group, and ## P < 0.01 versus the sham group. Data are the mean
Figure 9 (See legend on next page.)
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Figure 9 PI3K/Akt/GSK-3β and ERK1/2 signals are involved in the protective effect of bFGF both in SCI rats and PC12 cells under
stress. A. The protein expressions of p-Akt/Akt, p-ERK/ERK, p-GSK-3β/GSK-3β in the sham, SCI model and SCI rat treated with bFGF groups. B. The
optical density analysis of p-Akt/Akt, p-ERK/ERK, p-GSK-3β/GSK-3β protein. ** P < 0.01 versus the sham group, and # P < 0.05 versus the SCI group.
Data are the mean values ± SEM, n = 6. C. MTT results of the different concentrations of TG-treated PC12 cells. D. MTT result of NGF-treated PC12
cells induced by TG. E. FACScan result of PI/Annexin V-FITC staining for cell apoptosis analysis. F. Statistical result of apoptosis rate in PC12 cells
treated with TG and NGF. ** P < 0.01 versus the control group, and # P < 0.05 versus the TG group. Data are the mean values ± SEM, n = 3. G. The
protein expressions of CHOP, GRP78, p-Akt, p-ERK1/2, p-GSK-3β in ER stress-induced apoptosis PC12 cells treated with NGF and different inhibitors.
GAPDH was used as the loading control and for band density normalization. H. The optical density analysis of CHOP, GRP78, p-Akt, p-ERK1/2 and
p-GSK-3β protein. * P < 0.05 versus the control group, # represents P < 0.05 versus the TG group, $ P < 0.05 versus the TG + NGF group. Data are
the mean values ± SEM, n = 6.
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effect on cell death when used respectively [29,30]. The
activations of CHOP, p-Akt, p-ERK1/2 and p-GSK-3β
were determined by Western blot analysis. As shown in
Figure 9G and H, the activation of CHOP by TG treat-
ment was inhibited by NGF addition, but the protective
effect of NGF was abolished by LY294002 and PD98059,
the expression of CHOP increased significantly by the
inhibitors combination, compared with NGF treatment
group (P = 0.0049 and P = 0.0046). Meanwhile, the levels
of p-Akt, p-ERK1/2 and p-GSK-3β increased by NGF
treatment and decreased by inhibitors addition. All of
these data demonstrated the protective role of NGF in
the ER stress-induced apoptosis is related to the activa-
tion of downstream signals PI3K/Akt and ERK1/2 both
in vitro and in vivo.
Discussion
The failure of axons to regenerate following CNS trauma
results from decreased intrinsic properties of the neu-
rons [31], the most predominant features which related
to the recovery of SCI are the absence of neurotrophic
factors and the presence of inhibitory factors in the en-
vironment [32,33]. In this study, our goal was to identify
the cellular and molecular changes after acute spinal
cord injury and NGF treatment that improve locomotor
function of model rats.
Previous studies have demonstrated a variety of crucial
functions of NGF in the nervous system, which is associ-
ated with central neuronal plasticity. As a member of
neurotrophic factors, NGF was discovered as a molecule
that stimulates the survival and maturation of develop-
ing neurons in the peripheral nervous system and has
later been shown to protect adult neurons in the degen-
erating mammalian brain [34,35]. Zhang et al demon-
strated that treatment with recombinant DNA vaccine
promotes functional recovery in spinal cord hemisected
adult rats, associated with expression of endogeous NGF
significantly upregulated [36]. Besides, latest study inves-
tigated the possible protective actions of melatonin on
SCI-induced damage and urinary bladder dysfunction,
reduce of NGF levels due to SCI were restored bymelatonin treatment, suggest that melatonin reduces SCI-
induced tissue injury and improves bladder functions
through its effects on oxidative stress and NGF. Adminis-
tration with recombinant adenovirus encoding NGF along
saphe nous branch in transected femoral nerve, NGF
acted as a guidance molecule to promote branch point en-
trance of sensory axons into the saphenous branch, signifi-
cantly increased the accuracy of saphenous branch
neurons reinnervation [37]. In our study, treatment with
exogenous NGF increased the locomotor function pro-
gressively during the experimental period. Increased sur-
vival of neurons markedly, increased the level of GAP43
which is considered a crucial component of an effective
regenerative response in the nervous system, indicated
that exogenous NGF administration shown protective ef-
fect and improved the recovery of SCI.
It is well known that SCI is a process involving various
self-destructive processes that occur by a variety of fac-
tors based on disturbances in ionic homeostasis, local
edema, focal hemorrhage, excitotoxicity, presence of free
radicals and free fatty acids [38,39]. Certain studies have
indicated that neuronal and glial cell apoptosis plays a
role in SCI and that the inhibition of neuronal and oligo-
dendroglial apoptosis may be a therapeutic strategy
[40,41]. The results from the present study demon-
strated that the pathological changes of the neurons and
TUNEL-positive cells increased in the injured spinal
cord, which led to neuronal and glial cell loss, and finally
induced the impairment of locomotor activity according
to the BBB scale. Certain studies, have suggested that
the ER stress-signal may have a direct role in promoting
cell death in neuronal injury diseases [42,43]. CHOP
plays a critical role in ER stress-induced apoptosis, and
it is believed to play a central role in ER stress-induced
cell death, has been implicated in mediating neurode-
generation in animals with Alzheimer's disease [44].
CHOP activation has been observed in neurons under-
going apoptosis due to perturbations in ER calcium
levels in neurotoxin model of parkinsonism in vivo [45].
Following spinal cord injury, rats deficient in CHOP sig-
naling show increased spared white matter and en-
hanced locomotor recovery by 6 weeks. At 24 hours
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perfused microvessels. The expression increased levels of
CHOP in the rats with SCI revealed that CHOP-mediated
ER stress-induced apoptosis may be involved in SCI [46].
In vitro, it has also been indicated that NGF could protect
PC12 cells against ER stress induced by TG, the role of
pre-treatment NGF is related to the inhibition of Bax
translocation from cytosol to the mitochondria, which led
to loss of mitochondrial transmembrane potential, cyto-
chrome c release, activation of caspases and apoptosis
[21]. In this study, we demonstrated that ER stress-
induced apoptosis was involved in the responses of SCI,
the levels of related proteins including CHOP, GRP78 and
caspase-12 protein increased obviously and decreased by
treatment of NGF after 7d contusion in vivo, which also
been detected in PC12 cell injury models induced by TG,
suggested the neuroprotective effect of NGF was related
to the inhibition of chronic ER stress-induced apoptosis.
Early study has demonstrated that the role of NGF is
related to tyrosine kinase A (TrkA), and activation of
downstream signals [47], including PI3K/Akt/GSK-
3βand MEK/ERK1/2 [48-50]. Study has observed a time-
dependent and dose-dependent effect of NGF on the
PI3K/Akt and MAPK/ERK pathways, which also been
involved in the other neurothrophic factors such as basic
fibroblast growth factor in our previous studies of the
recovery of SCI [26]. It has reported that localized mi-
crodomains of axonal PI3K activity drive the activity of
axonal F-actin patches which essential for the formation
of filopodia and branches from the axon, and show that
NGF increases the formation of axonal filopodia by sig-
naling through PI3K-Akt [51]. Other latter findings are
consistent with the key role of PI3K and ERK signals in
sensitization of TRPV1 by NGF and may explain the
previously published observation that adult, but not neo-
natal, rat dorsal root ganglion neurons are sensitized by
NGF [52]. Besides, NGF protects dorsal root ganglion
neurons from oxaliplatin by modulating JNK/Sapk and
ERK1/2, the findings assess the validity of MAPKs as the
target of neuroprotective therapies during chemothera-
peutic treatment. Moreover they also describe a double
role for ERK1/2, depending on cellular stimulation, since
it mediates neuronal apoptosis after oxaliplatin exposure
[53]. When a specific inhibitor of PI3K, LY294002, was
added to glucose analog 2-deoxy-D-glucose plus NGF-
treated PC12 cells, both the effects of NGF on 2DG-
induced apoptosis and GRP78 expression were signifi-
cantly diminished [19]. In our study, the protective effect
of NGF was also abolished by specific inhibitors
LY294002 and PD98059, confirmed that the protective
role of NGF here is related to the activation of down-
stream signals PI3K/Akt/GSK-3β and ERK1/2 in ER
stress-induced apoptosis. In the following study, to fur-
ther confirmed the role of NGF and the relations withchronic ER stress in the recovery of SCI model, siRNA
of CHOP or ATF4 should be applied, which may contributes
to the evidences of NGF protection through regulation
of ER stress in neuronal cell death in vivo. Even so, over
the past 30 years neurotrophic factors have generated
considerable excitement for their potential as therapy
for a wide variety of neurological disorders, for which
there is currently no treatment. NGF appeared to be ef-
ficacious in two phase II clinical trials, but failed in a
large scale phase III trial, to explore the appropriate
therapeutic time window and special drug delivery sys-
tem combined with factors still need long-term study. It
also need to be addressed that NGF is not stable enough
which is easy to be degradated by various enzymes
in vitro, resulting in the loss of biological activity. So the
combination with other drugs or delivery systems to in-
crease its stability and smoothly through the spinal cord
barrier may contributes to the functions of NGF. While
the therapeutic potential of NGF has been well-recognized
for decades, attempts to translate that potential to the
clinic have been disappointing, largely due to significant
delivery obstacles. Moreover, the mechanism of traumatic
CNS injury diseases also undefined clearly, this study lays
the ground work for future translational confidence of
NGF in CNS diseases, especially the relations to ER stress.
Collectively, the translational application study of NGF
may not only focus on the effect in the neurogenesis, the
combination with special biomaterials which can improves
the efficiency and prolongs the effective time should also
be addressed.
In conclusion, our research demonstrated that treat-
ment with exogenous NGF increased the survival of
neurons in the spinal cord lesions and improved the
functional recovery of acute spinal cord injury model
rats. Inhibition of ER stress induced apoptosis and in-
crease of neuroprotective factor GAP43 is involved in
the role of NGF in the neuronal cell death both in vivo
and in vitro. These data demonstrate that therapeutic
strategies targeting on chronic ER stress with NGF
which also plays neurotrophic effects may be suitable for
the therapy of central nervous system injuries, the effect-
ive combination with special drug delivery system or
other factors still need to further investigations.
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